Whether developing oral biologics, complex peptides, targeted delivery systems or other novel therapeutic modalities, generating reliable bioanalytical data is essential for making informed development decisions.
Veloxity partnered with Toralgen to provide:
Together, the teams generated the data supporting evaluation of Toralgen’s proprietary oral biologics platform.
Learn how Toralgen and Veloxity collaborated to generate the bioanalytical data supporting evaluation of a novel oral biologics platform.
Toralgen announced positive preclinical findings demonstrating successful oral delivery across multiple diabesity peptide classes using its proprietary pUDCA
nanoparticle platform. Veloxity Labs partnered throughout the program, providing bioanalytical method development, assay validation, advanced LC-MS/MS analysis and pharmacokinetic expertise to generate the data used to evaluate platform performance and support development.
Whether your organization is developing:
Veloxity provides specialized bioanalytical expertise to help companies developing complex therapeutics generate reliable data, address analytical challenges and make informed development decisions.
Bringing an innovative therapeutic platform to the next development milestone requires more than analytical testing. It requires a scientific partner who understands the complexities of emerging modalities, adapts to evolving program needs and delivers data you can trust.
Veloxity combines deep scientific expertise with responsive collaboration to help clients navigate complex bioanalytical challenges with confidence.
When development timelines are compressed, every day matters. Veloxity’s experienced team, streamlined processes and collaborative approach support rapid study initiation and execution.
Our scientists bring decades of experience supporting pharmaceutical and biotechnology companies across preclinical and clinical development. From study design through data interpretation, we work alongside your team to solve complex analytical challenges and support informed decision-making.
Emerging therapeutic modalities demand specialized analytical approaches. Veloxity has experience supporting complex peptides, biologics, GLP-1 therapeutics and other
advanced modalities, helping clients address the analytical challenges these programs present.
Our LC-MS/MS and HRMS capabilities support sensitive, selective measurement of complex molecules across a range of study types. Combined with scientific expertise, these technologies help generate reliable data for development decisions.
No two therapeutic programs are alike. Veloxity develops fit-for-purpose bioanalytical methods tailored to the molecule, matrix, study objectives and applicable regulatory expectations.
We believe the best outcomes come from collaboration. Clients work directly with experienced scientists who are accessible, proactive and invested in the success of each program. From project kickoff through final reporting, Veloxity serves as an extension of your scientific team.
Whether you need end-to-end bioanalytical support or specialized expertise for a single phase of development, Veloxity adapts to your program’s unique requirements.
Our team works alongside your scientists to provide:
✓ Bioanalytical method development
✓ Assay validation
✓ LC-MS/MS and HRMS analysis
✓ Pharmacokinetic expertise
✓ Scientific consultation
✓ Responsive project support
Let’s discuss the bioanalytical needs of your program and how Veloxity can support your next development milestone.
